摘要
为探讨冠心病(CHD)患者脂蛋白(a)[Lp(a)]水平与肾脏早期损害的关系,应用ELISA法及化学显色终点法分别检测36例CHD患者血清Lp(a)水平和尿氨基葡萄糖耷酶(NAG)活力。结果,CHD组血Lp(a)及尿NAC均明显高于正常对照组,且Lp(a)值与尿NAC活力呈正相关(r=0.42P<0.01),提示。
The serum level of lipoprotein(2)and the urinary level of N-acetyl-Glucosaminidase(NAG)were determined in 36 patients with coronary heart disease and 30 normal controls,The results showed that the serum Lp(a)and urinary NAG were remarkably increased in these patients in comparison with the controls(P<0.001,P<0.01).The serum Lp(a)and urinary NAG was positive correlated (R=0.42,P<0.01).It is suggested that LP(a)level is risk factor in early damage of kidneys in the patients with coronary heart disease.
出处
《贵州医药》
CAS
1999年第6期410-411,共2页
Guizhou Medical Journal
关键词
冠心病
脂蛋白(a)
尿酶
肾脏损害
Coronary heart disease, Lipoprotein(a),N-Acety-Glucosaminidase